You are adding an alert for:
Assessment of pre-trial bevacizumab response in the REACT study: A prospective comparative dosing trial of ranibizumab in eyes previously treated with bevacizumab.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: